Literature DB >> 9451756

Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder.

P D Sampson1, A P Streissguth, F L Bookstein, R E Little, S K Clarren, P Dehaene, J W Hanson, J M Graham.   

Abstract

We critique published incidences for fetal alcohol syndrome (FAS) and present new estimates of the incidence of FAS and the prevalence of alcohol-related neurodevelopmental disorder (ARND). We first review criteria necessary for valid estimation of FAS incidence. Estimates for three population-based studies that best meet these criteria are reported with adjustment for underascertainment of highly exposed cases. As a result, in 1975 in Seattle, the incidence of FAS can be estimated as at least 2.8/1000 live births, and for 1979-81 in Cleveland, approximately 4.6/1,000. In Roubaix, France (for data covering periods from 1977-1990), the rate is between 1.3 and 4.8/1,000, depending on the severity of effects used as diagnostic criteria. Utilizing the longitudinal neurobehavioral database of the Seattle study, we propose an operationalization of the Institute of Medicine's recent definition of ARND and estimate its prevalence in Seattle for the period 1975-1981. The combined rate of FAS and ARND is thus estimated to be at least 9.1/1,000. This conservative rate--nearly one in every 100 live births--confirms the perception of many health professionals that fetal alcohol exposure is a serious problem.

Entities:  

Mesh:

Year:  1997        PMID: 9451756     DOI: 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  201 in total

1.  Peripubertal paternal EtOH exposure.

Authors:  N V Emanuele; N LaPagli; J Steiner; A Colantoni; D H Van Thiel; M A Emanuele
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

Review 2.  Mechanisms of ethanol-induced death of cerebellar granule cells.

Authors:  Jia Luo
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

3.  Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.

Authors:  Katherine Tassiopoulos; Jennifer S Read; Susan Brogly; Kenneth Rich; Barry Lester; Stephen A Spector; Ram Yogev; George R Seage
Journal:  AIDS Behav       Date:  2010-12

4.  Relation over time between facial measurements and cognitive outcomes in fetal alcohol-exposed children.

Authors:  Tatiana Foroud; Leah Wetherill; Sophia Vinci-Booher; Elizabeth S Moore; Richard E Ward; H Eugene Hoyme; Luther K Robinson; Jeffrey Rogers; Ernesta M Meintjes; Christopher D Molteno; Joseph L Jacobson; Sandra W Jacobson
Journal:  Alcohol Clin Exp Res       Date:  2012-03-08       Impact factor: 3.455

5.  Fetal alcohol spectrum disorder.

Authors:  Gideon Koren; Irena Nulman; Albert E Chudley; Christine Loocke
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

6.  Older not wiser: risk of prenatal alcohol use by maternal age.

Authors:  Laurie L Meschke; Joyce Holl; Sara Messelt
Journal:  Matern Child Health J       Date:  2013-01

Review 7.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

8.  Fetal alcohol spectrum disorders: Clinical phenotype among a high-risk group of children and adolescents in Korea.

Authors:  Hyun-Seung Lee; Kenneth Lyons Jones; Hae Kook Lee; Christina D Chambers
Journal:  Am J Med Genet A       Date:  2015-09-17       Impact factor: 2.802

9.  Developmental Trajectories for Visuo-Spatial Attention are Altered by Prenatal Alcohol Exposure: A Longitudinal FMRI Study.

Authors:  P Gautam; S C Nuñez; K L Narr; S N Mattson; P A May; C M Adnams; E P Riley; K L Jones; E C Kan; E R Sowell
Journal:  Cereb Cortex       Date:  2014-08-04       Impact factor: 5.357

10.  Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure.

Authors:  B Lewis; K A Wellmann; S Barron
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.